Tiziana Competitors

TLSA Stock  USD 0.96  0.01  1.05%   
Tiziana Life Sciences competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Tiziana Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Tiziana Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Tiziana Life Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Tiziana Life competition on your existing holdings.
  
As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.58. In addition to that, Return On Capital Employed is expected to decline to -0.89. At present, Tiziana Life's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 157 K, whereas Total Assets are forecasted to decline to about 10.9 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tiziana Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.050.977.68
Details
Intrinsic
Valuation
LowRealHigh
0.071.448.15
Details
1 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details

Tiziana Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Tiziana Life and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Tiziana and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Tiziana Life Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SCPHELYM
MCRBELYM
MCRBSCPH
LUMOMIST
  
High negative correlations   
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTELYM
MISTSCPH
MCRBMIST

Risk-Adjusted Indicators

There is a big difference between Tiziana Stock performing well and Tiziana Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tiziana Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Tiziana Life Sciences and related stocks such as Eliem Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals Net Income Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D ADividend Yield
RoicPayables Turnover
RoeReturn On Tangible Assets
Earnings YieldReceivables Turnover
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Capital EmployedFixed Asset Turnover
Return On AssetsAsset Turnover
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
SCPH(10.5 M)(10.5 M)(10.5 M)(10.5 M)(10.5 M)(10.5 M)(24.4 M)(23.8 M)(29.4 M)(34.4 M)(34.4 M)(30.5 M)(37.5 M)(54.8 M)(52.1 M)
MIST(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(8.1 M)(23.2 M)(55.2 M)(50 M)(42.6 M)(57.1 M)(59.7 M)(62.7 M)
MCRB(3.1 M)(3.1 M)(3.1 M)(6.1 M)(16.7 M)(54.8 M)(91.6 M)(89.4 M)(98.9 M)(64.2 M)(86.5 M)(61.5 M)(253.8 M)(113.7 M)(119.4 M)
LUMO(9.2 M)(18.1 M)(23.3 M)(31.2 M)102.9 M(40.4 M)(85.2 M)(72 M)(53.6 M)(43 M)(5.7 M)(30.4 M)(31.1 M)(34 M)(35.7 M)

Tiziana Life Sciences and related stocks such as Eliem Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Tiziana Life Sciences financial statement analysis. It represents the amount of money remaining after all of Tiziana Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Tiziana Life Competitive Analysis

The better you understand Tiziana Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Tiziana Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Tiziana Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
TLSA ELYM SCPH MIST MCRB LUMO
 1.05 
 0.96 
Tiziana
 2.91 
 3.00 
Eliem
 1.79 
 3.41 
Scpharmaceuticals
 0.54 
 1.85 
Milestone
 15.58 
 0.89 
Seres
 0.23 
 4.30 
Lumos
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Tiziana Life Competition Performance Charts

Five steps to successful analysis of Tiziana Life Competition

Tiziana Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Tiziana Life Sciences in relation to its competition. Tiziana Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Tiziana Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Tiziana Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Tiziana Life Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Tiziana Life position

In addition to having Tiziana Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Basic Utilities Thematic Idea Now

Basic Utilities
Basic Utilities Theme
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tiziana Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tiziana Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tiziana Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tiziana Life Sciences Stock:
Check out Tiziana Life Correlation with its peers.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tiziana Life. If investors know Tiziana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tiziana Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.13)
Revenue Per Share
(0.02)
Return On Assets
(0.70)
Return On Equity
(1.81)
The market value of Tiziana Life Sciences is measured differently than its book value, which is the value of Tiziana that is recorded on the company's balance sheet. Investors also form their own opinion of Tiziana Life's value that differs from its market value or its book value, called intrinsic value, which is Tiziana Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tiziana Life's market value can be influenced by many factors that don't directly affect Tiziana Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tiziana Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tiziana Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tiziana Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.